BDX completes its Biosciences & Diagnostic spin-off and Waters merger, securing $4B in proceeds as it pivots to a pure-play ...

Becton Dickinson (NYSE:BDX) received FDA clearance for its Surgiphor 1000mL antimicrobial irrigation system, expanding its surgical solutions portfolio. The company also launched the BD Vacutainer ...

Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution model Doubles Waters' total addressable market to ...

Compelling opportunity expected to unlock substantial value through enhanced focus, tailored investment and capital allocation, and optimized market valuation "New BD," built on momentum of BD 2025 ...

FRANKLIN LAKES, N.J., Feb. 9, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) today announced the successful completion of the previously announced spin-off of BD's Biosciences & ...

FRANKLIN LAKES, N.J. and AUSTIN, Texas, Dec. 17, 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Babson Diagnostics, a ...

The flexibility of the technology will allow BD to expand beyond infectious disease-related offerings. BD is taking over HandyLab for its molecular diagnostic assays and automation platforms. BD plans ...

Nearly three years after Beckon Dickinson spun off its diabetes care unit, the Franklin Lakes-based global medical technology company aims to slim down even further to focus on its core business. As ...

Waters Corporation (NYSE: WAT) and BD (Becton, Dickinson and Company) (NYSE: BDX) today announced a definitive agreement to combine BD's Biosciences & Diagnostic Solutions business with Waters, ...

(RTTNews) - Medical technology company Becton, Dickinson and Co. or BD (BDX), and health care technology company Babson Diagnostics, announced Tuesday an expansion of fingertip blood collection and ...